GOHEALTH INC-CLASS A (GOCO) Stock Analyst Ratings
USA - NASDAQ:GOCO - US38046W2044 - Common Stock
3.96 USD
-0.06 (-1.49%)
3.96 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 82% to GOCO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 19.38. This target is 389.39% above the current price.
GOCO was analyzed by 11 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about GOCO.
In the previous month the buy percentage consensus was at a similar level.
GOCO was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-28 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-05-19 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-10-21 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-03-20 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2023-04-04 | Credit Suisse | Maintains | Underperform |
| 2023-03-17 | RBC Capital | Maintains | Sector Perform |
| 2022-08-26 | RBC Capital | Maintains | Sector Perform |
| 2022-08-16 | Credit Suisse | Maintains | Underperform |
| 2022-03-03 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2022-03-02 | Truist Securities | Downgrade | Buy -> Hold |
| 2022-01-07 | Credit Suisse | Downgrade | Neutral -> Underperform |
| 2022-01-05 | B of A Securities | Downgrade | Buy -> Underperform |
| 2021-11-15 | Credit Suisse | Maintains | Neutral |
| 2021-11-11 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-11-10 | RBC Capital | Maintains | Outperform |
| 2021-11-10 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2021-11-09 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2021-08-13 | Barclays | Maintains | Overweight |
| 2021-08-12 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2021-08-12 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2021-08-12 | Credit Suisse | Downgrade | Outperform -> Neutral |
| 2021-08-12 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-05-17 | Raymond James | Maintains | Outperform |
| 2021-05-17 | Credit Suisse | Maintains | Outperform |
| 2021-05-14 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-03-15 | Raymond James | Maintains | Outperform |
| 2021-03-10 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-03-09 | Credit Suisse | Maintains | Outperform |
GOHEALTH INC-CLASS A / GOCO FAQ
What is the average price target for GOHEALTH INC-CLASS A (GOCO) stock?
11 analysts have analysed GOCO and the average price target is 19.38 USD. This implies a price increase of 389.39% is expected in the next year compared to the current price of 3.96.
What is the consensus rating for GOCO stock?
The consensus rating for GOHEALTH INC-CLASS A (GOCO) is 81.8182 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed GOHEALTH INC-CLASS A (GOCO)?
The number of analysts covering GOHEALTH INC-CLASS A (GOCO) is 11.